23andMe, Regeneron
Digest more
The new owner, Regeneron Pharmaceuticals intends to continue providing 23andMe’s consumer genome services, it said.
What happened to 23andMe? Here's a look at its history from launch to bankruptcy and acquisition by Regeneron.
The pharmaceutical giant plans to continue offering 23andMe’s DNA testing service and pledged to adopt its privacy practices to protect customer data.
The fall of 23andMe raises privacy concerns as Regeneron buys its genetic database for $256M after bankruptcy.
Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer consumer DNA testing services.
Attorney General Gentner Drummond is alerting Oklahoma consumers in the wake of 23andMe having filed for bankruptcy protection last month. The genetic testing company, which collects and analyzes the genetic code of consumers,